(Q34571335)

English

Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

James M. Brophy

object named as

James M Brophy

5

0 references

author name string

Verena Schneider

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Linda E Lévesque

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Bin Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Thomas Hutchinson

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

27 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

American Journal of Epidemiology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

164

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

881-889

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Renal syndromes associated with nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Nonsteroidal anti-inflammatory drugs: effects on kidney function

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Anti-inflammatory agents and renal function

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure.

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Renal failure associated with the use of celecoxib and rofecoxib

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidence

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Raising the safety bar--the FDA's coxib meeting

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

A chronic disease score from automated pharmacy data

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Cyclooxygenase-2 inhibition and renal physiology

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Factors associated with celecoxib and rofecoxib utilization

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important?

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWJ331

21 January 2018

Identifiers

10.1093/AJE/KWJ331

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34571335&oldid=1637275634"